S2326. Paucicellular myxoid liposarcoma 1 Histiocytic sarcoma 1 Alveolar soft part sarcoma 1 Perivascular epithelioid cell tumor (PEComa) 1
|
|
|
- Abel Stone
- 5 years ago
- Views:
Transcription
1 S2325 Encephalitis 21 Encephalitis 4 Cerebritis 1 Meningoencephalitis 4 Acute disseminated encephalomyelitis 2 Acute encephalitis(virus) 1 Herpes simplex encephalitis* 2 Encephalitis, viral infection? 1 Cryptococcal encephalitis 3 Varicella-Zoster encephalitis 1 Meningitis, Cryptococcus? 1 Leptomenigitis vs ML? 1 Malignant lymphoma 11 Malignant lymphoma,nos 8 Intravascular large B-cell lymphoma 1 Intravascular lymphoma 1 ML, NHL, diffuse large 1 Others Ganglioglioma 1 Diffuse astrocytoma 1 Oligoastrocytoma 1 Oligodendroglioma 2 Demyelinating disease 1 Cortical dysplasia 2 Plasmacytoma 1 Plasma cell dyscrasia 1 Primary angitis of CNS 3 IDK 2
2 S2326 Granular cell tumor 32 Granular cell tumor 19 Granular cell tumor, malignant 12 Granular cell tumor, unceratin malignant potent 1 Angiosarcoma 6 Angiosarcoma 2 Angiosarcoma, granular cell variant* 2 Foamy cell angiosarcoma 1 Hemangiopericytoma 1 Paucicellular myxoid liposarcoma 1 Histiocytic sarcoma 1 Alveolar soft part sarcoma 1 Perivascular epithelioid cell tumor (PEComa) 1 Rosai-Dorfman disease 1 Histiocytosis 2 Xanthoma 4 Clear cell atypical fibroxanthoma 1 Benign fibrous histiocytoma 1 Balloon cell melanoma 1 Sebaceous carcinoma 1 Metastatic carcinoma 1 Metastatic renal cell carcinoma 1
3 S2327 Schwannoma 19 Nasal schwannoma 1 Perineurioma 1 Neurofibroma 15 Pigmented neurofibroma 1 Neurofibroma with atypia 1 Neurogenous tumor 1 Hybrid peripheral nerve sheath tumor (schwannoma-neurofibroma- 4 Hybrid schwannoma/perineurioma 1 Malignant peripheral nerve sheath tumor 9 MPNST, arising in neurofibroma 1 Peripheral nerve sheath tumor 1 Low grade peripheral nerve sheath tumor 1 Peripheral nerve tumor, benign 1 Inflammatory myofibroblastic tumor 3 Low grade fibromyxoid sarcoma 1 Solitary fibrous tumor 2 Giant cell angiofibroma 1 Desmoid type fibromatosis 1 Fibroma 1 Benign fibrous histiocytoma 1 Meningioma 1
4 S2328 Secretory carcinoma 24 Secretory carcinoma with apocrine differentiation 1 Secretory carcinoma* 23 Apocrine carcinoma 5 Apocrine carcinoma 3 Apocrine carcinoma, non-invasive 1 Apocrine ductal carcinoma 1 ductal carcinoma Invasive ductal carcinoma 2 Papillotubular carcinoma 1 Invasive cribriform carcinoma 3 Adenocarcinoma,NOS 1 Adenocarcinoma of low grade malignancy 1 Intracystic papillary carcinoma 1 Intracystic tubular carcinoma 1 Noninvasive ductal carcinoma (intracystic carcinom 1 Tubular adenocarcinoma 1 Mucinous carcinoma 1 Adenoid cystic carcinoma 1 Oncocytic carcinoma 3 Subareolar tubular carcinoma 1 DCIS, low grade 1 Others, malignant Carcinoid 2 Carcinoma with endocrine features 1 Endocrine carcinoma 1 Neuroendocrine carcinoma 2 Neuroendocrine DCIS 1 Others, benign Ductal adenoma 4 Ductal adenoma with tubular features 1 Ductal adenoma, with apocrine differentiation 1 Tubular adenoma 1 Papilloma 1 Apocrine adenoma 1 Adenomyoepithelioma 1 Apocrine metaplasia in intracystic hyperplasia 1 Fibromatosis 1
5 S2329 Invasive ductal carcinoma 3 Ductal carcinoma 1 Apocrine carcinoma* 7 Apocrine carcinoma, non-invasive 4 Cystic hyper secretory carcinoma 2 Secretory carcinoma 1 Noninvasive ductal carcinoma (DCIS) 5 DCIS+apocrine metaplasia 1 DCIS in radial scar 1 DCIS with apocrine feature / Premalignant? 1 Intraductal papillary carcinoma 1 Lobular carcinoma in situ (LCIS) 3 DCIS+LCIS 7 DCIS+LCIS(pleomorphic) 1 Pleomorphic apocrine LCIS and apocrine DCIS 1 Mixed ductal and lobular carcinoma-in-situ, with apocrine metaplasia in 1 LCIS DCIS+ILC 1 Combined ductal and lobular carcinoma 2 Neuroendocrine carcinoma 1 Plemorphic carcinoma 2 Atypical apocrine adenosis 1 Atypical ductal hyperplasia 1 Ductal adenoma 1 Duct papillomatosis 1 Mastopathy 1
6 S2330 Adenocarcinoma, NOS 1 Acinar cell carcinoma 3 Acinar cell carcinoma+myoepithelial carcinoma 1 Acinic cell carcinoma + myoepithelioma 1 Carcinoma ex pleomorphic adenoma 5 Carcinoma (myoepithelial carcinoma) ex pleomorphic adenoma* 1 Polymorphous low-grade adenocarcinoma 10 Myoepithelial carcinoma 9 Epithelial-myoepithelial carcinoma 5 Basaloid SCC + Acinic cell carcinoma 1 Intraductal papillary carcinoma 1 Myoepithelial carcinoma + Oncocytosis 2 Sq.C.C and oncocytoma 1 Sarcomatoid squamous cell carcinoma 1 Dedifferentiated acinic cell carcinoma 1 Carcinosarcoma 1 Pleomorphic adenoma 9 Myoepithelioma 9 Myoepithelioma, oncocytic change 2 Basal cell adenoma 1 Epithelioid hemangioendothelioma 1 Epithelioid hemangiom 1
7 S2331 Thymolipoma* 44 Myelolipoma 6 Lipoma 1 Thymoma 1 Type B1 thymoma 1 Thymoma with saquamons differrentiation 1 Hamartomatous thymoma 1 Teratoma 1 Thymic carcinoma 1 Chronic mediastinitis 1 Fat degeneration 1
8 S2332 Castleman's disease 10 Multicentric Castleman's disease 5 Kaposi sarcoma + Castleman disease 2 Kaposi sarcoma + multicentric Castleman disease* 1 Kaposi sarcoma 7 Vasoproliliferative and spindle cell lesion, including Kaposi's sarcoma 1 HIV lymphadenitis 5 HHV8-associated multicentric Castleman's disease 1 IgG4 related lymphadenopathy 6 IgG4-related lymphadenopathy, type III 1 IgG4-related lymphoadenophathy, ALPIBP type 1 Malignant lymphoma 6 Angioimmunoblastic T-cell lymphoma 4 Diffuse lymphoma 1 Follicular lymphoma 2 Mantle cell lymphoma 1 Marginal zone B-cell lymphoma 1 Polymorphic B-cell lymphoma (PTLD-like) + Kaposi's sarcoma 1 Inflammatory pseudotumor 1 Inflammatory myofibroblastic tumor 1 Bacillary angiomatosis 2 Syphilitic lymphadinitis 1 Lymphadenopathy 2 Reactive lymphoid hyperplasia 1
9 S2333 Desmoplastic small round cell tumor* 51 Desmoplastic small round cell tumor with rhabdoid feature 3 Rhabdomyosarcoma 6 Rhabdoid tumor 2 Malignant extrarenal rhabdoid tumor 1 Malignant rhabdoid tumor 1 Neuroblastoma 1 Ganglioneuroblastoma 1
10 S2334 Cellular angiofibroma* 10 Aggressive angiomyxoma 3 Angiomyofibroblastoma 5 Angiomyofibroblastoma like tumor 4 Lipomatous angiofibroblastoma 1 Angiomyofibroma 1 Mammary type myofibroblastoma 1 Low grade fibromyxoid sarcoma 2 Liposarcoma 4 Sclerosing liposarcoma 2 Well differentiated liposarcoma, sclerosing type 2 Well-differentiated liposarcoma 1 Angiomyolipoma 1 Myolipoma 1 Spindle cell lipoma 2 Fibrolipoma 5 Giant fibrolipoma 1 Fibrolipomataous tumor 1 Solitary fibrous tumor 5 Inflammatory pseudotumor 1 Fibrous pseudotumor 3 Fibroma 1 Fibromatosis 1 Schwannoma 1 Thecoma/fibroma group 3 Calcifying fibrous tumor 1 Fibromatous periorchitis 2 Nodular fasciitis 1
11 S2335 Malignant Brenner tumor 6 Transitional cell carcinoma 17 Transitional cell carcinoma + germ cell tumor 1 Transitional cell carcinoma + serons adenocarcinoma 1 Transitional cell carcinoma and clear cell carcinoma 1 Transitional cell carcinoma due to inherited tumor syndrome 1 Transitional cell carcinoma with serous adenocarcinoma 1 Serous adenocarcinoma and transitional cell carcinoma 1 Serous cyst adenocarcinoma + Brenner 1 Malignant mixed epithelial tumor* 1 Malignant mixed tumor(serouscyst adenocarcinoma + clear cell ) 1 Mixed carcinoma 1 Mixed epithelial carcinoma (familial breast and ovary carcinoma syndrome) 1 Mixed epithelial tumor (transitional cell ca.+serous ca.+clear cell 1 Mixed epithelial tumor, malignant 1 Bilateral malignant Brenner tumor + breast cancer 1 BRCA1 syndrome (clear cell adenocarcinoma + transitional cell carcinoma ) 2 Serous adenocarcinoma 3 Clear cell adenocarcinoma 5 Embryonal carcinoma 1 Endometrioid adenocarcinoma 1 Endometrioid adenocarcinoma + yolk sac tumor 1 Gonadoblastoma 1 Granulosa cell tumor 1 Juvenile granulosa cell tumor 1 Adenocarcinoma, NOS 3 Adenocarcinoma, probable ovarian origin 1 Metastatic carcinoma 3 Breast carcinoma, metastatic to ovary 1 Poorly differentiated adenocarcinoma 1 Mixed germ cell tumor 1 Mixed germ cell tumor (yolk sac tumor + embryonal carcinoma + choriocarcinoma) 1
12 S2336 Benign metastasizing leiomyoma 7 Benign metastasizing leiomyoma (leiomyomatosis of the pelvic lymph nod 1 Leiomyomatosis 12 Smooth muscle proliferation of nodal hilum 1 Lymphangiomyomatosis 16 Lymphangioleiomyoma 2 Lymphangiomyoma 1 Angiomyolipoma 2 Angiomyomatosis 4 Vascular transformation of lymph node sinuses 2 Sinus histiocytosis 1 Sinus histiocytosis with massive lymphadenopathy 1 Tumor-reactive lymphadenopathy, reactive sinus histiocytosis type 1 IgG4-related lymphadenopathy, type V 1 Endometrial stromal sarcoma 1 Fibroblastic reticular cell tumor 1 MALT lymphoma 1 Lympho-reticular hyperplasia 1 Schwannoma 1 Nevus cell inclusion 1 Metastasis of leiomyosarcoma 1
13 S2337 Granular cell tumor 10 Oncocytoma 9 Oncocytic carcinoma 7 Oncocytic carcinoid* 6 Oncocytic tumor with lymphoid stroma 2 Paraganglioma 3 Hepatoid adenocarcinoma 4 Acinar cell carcinoma in ectopic pancreas 2 Gastric carcinoma with lymphoid stroma 2 Parietal cell adenocarcinoma 2 Medullary carcinoma 1 Adenocarcinoma of fundic gland type 1 Poorly differentiated carcinoid tumor 1 Carcinoma, NOS 1 Oxyphilic cell carcinoma, metastatic? 1 Metastatic cancer derived from pancreatic islet 1 Metastatic hepatocellular carcinoma 1 Ectopic pancreas 2 Oncocytosis of ectopoc pancreas 1 Heterotopic gastric glands with oxiphilic chage 1 Small lymphocytic lymphoma obscured by epithelioid histiocytes 1 Neuroendocrine cell tumor 1 Epithelioid leiomyoma 1 Langerhans histiocytosis 1 Warthin's tumor 1
14 S2338 GIST 38 Gastrointestinal stromal tumor* 21 Gastrointestinal stromal tumor, high risk 4 Gastrointestinal stromal tumor with rhabdoid feature 5 Gastrointestinal stromal tumor, epitehlioid 4 Gastrointestinal stromal tumor, intermediate risk 1 Epithelioid malignant GIST 1 Epithelioid GIST with rhabdoid feature 1 PDGFRA-mutated GIST 1 Leiomyosarcoma 7 Leiomyosarcoma 4 Leiomyosarcoma with rhabdoid features 1 Epithelioid leiomyosarcoma 2 Rhabdoid tumor 14 Rhabdoid tumor 7 Rhabdoid tumor, malignant 7 Epithelioid sarcoma 1 Angiosarcoma 1 Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation 1 Neuroendocrine tumor 1 Carcinoid tumor 1 Endocrine carcinoma 1 Plasmacytoma 1 Synovial sarcoma 1 Metastatic synovial sarcoma 1 Glomus tumor 1 Granular cell tumor 1 Epithelioid leiomyoma 1
15 S2339 Adenocarcinoma 54 Adenocarcinoma, NOS 18 Moderately diff. tubular adenocarcinoma 1 Poorly differentiated adenocarcinoma 4 Adenocarcinoma with chondroid differentiation 2 Adenocarcinoma with chondromyxoid matrix 1 Adenocarcinoma with focal chondroid metaplasia 2 Adenocarcinoma with matrix-production 4 Adenocarcinoma with mucoid stroma 1 Adenocarcinoma with oncocytic change and matrix-producing appeara 1 Adenocarcinoma with prominent vascular invasion 1 Adenocarcinoma with trophoblastic differentiation 1 Adenocarcinoma, parietal cell type 1 Adenocarcinoma with neuroendocrine carcinoma 2 AFP-producing carcinoma 3 Hepatoid adenocarcinoma 1 Tubular adenoca with adenoid cystic pattern 1 Neuroendocrine cell carcinoma 4 Gastric carcinoma with enteroblastic differentiation 2 Adenocarcinoma and endoarteritis 1 Tubular adenocarcinoma + intravascular fasciitis 1 Composite carcinoma 1 Choriocarcinoma + Adenocarcinoma 1 Carcinosarcoma 12 Carcinosarcoma* 12 Choriocarcinoma 1 Intravascular fasciitis 1
16 S2340 Adenocarcinoma,NOS 1 Gastric carcinoma with lymphoid stroma 22 Gastric medullary carcinoma 1 Medullary carcinoma with lymphoid stroma 4 Adenosquamous carcinoma 1 EBV related gastric cancer 1 Undifferentiated carcinoma with lymphoid stroma 1 Histiocytic sarcoma 2 Langerhans cell sarcoma 1 Lymphoepithelial carcinoma 4 Lymphoepithelioma like carcinoma 8 Malignant lymphoma 2 Follicular dendric cell tumor / sarcoma 10 Dendritic cell sarcoma 2 Cytokeratin-positive interstitial retivculum cell tumo 1 Follicular lymphoma 1 Anaplastic large cell lymphoma 1 Langerhans histiocytosis 1 Rosai-Dorfman disease 2
17 S2341 Juvenile polyp 21 Non-juvenile juvenile polyp 1 Hamartomatous polyp 7 Hamartomatous polyp with focal bizarre stromal cellular react 1 Serrated adenoma in hamartomatous polyp 1 Peutz-Jeghers type polyp 4 Peutz-Jagher`s polyp with protozoa infection 1 Cronkhite-Canada disease 1 Inflammatory myoglandular polyp* 21 Inflammatory polyp 2 Cap polyposis 2 Hyperplastic polyp 2 Non-neoplastic polyp 1 Malignant transformation of colorectal polyp 1
18 S2342 Adenocarcinoma 51 Adenocarcinoma,NOS 17 Adenocarcinoma (poorly derived from well ca.) 1 Adenocarcinoma + carcinoid tumor 1 Adenocarcinoma + endocrine cell carcinoma 1 Adenocarcinoma with clear cell change 2 Adenocarcinoma with hepatoid differentiation 1 Adenocarcinoma with neurocoendocrine differrentiation 2 Adenocarcinoma(papillary and clear cell) 1 Adenocarcinoma, well diff.+poorly diff. 1 Adenoendocrine cell carcinoma 3 AFP producing GB carcionoma* 4 Clear cell adenocarcinoma 7 Clear cell carcinoma(afp+) 1 Combined adenocarcinoma and neuroendocrine carcinoma 1 Combined clear cell adenocarcinoma and well differentiated tubular adenocarcin 1 Papillary adenocarcinoma 1 Papillary adenocarcinoma with carcinoid 1 Papillary adenocarcinoma with tubular carcinoma 1 Papillotubular carcinoma+carcinoma with enteroblastic differentiation 1 Poorly differentiated adenocarcinoma 2 Tubular adenocarcinoma + Clear cell adenocarcinoma 1 Tubulopapillary adenoma 1 Villous adenocarcinoma+rectal adenocarcinomaの転移 1 Carcinosarcoma 1
19 S2343 Amyloid deposition 26 Intestinal amyloidosis 1 Lymphocytic colitis with amyloidosis 1 Idiopathic mesenteric phlebosclerosis 2 Mestenteric phlebosclerosis 1 Phlebosclerotic colitis* 4 Collagenous colitis 11 A-V malformation 1 Colitis 1 Enteropathy-associated T cell lymphoma 1 Spirochetosis 1 Stromal fibrosis 1 MALT lymphoma 1 IDK 1
S2199 S2200. * Speaker's diagnosis 78
98 21 2 14 13:30 * Speaker's diagnosis 78 S2199 Meningioma 48 Papillary meningioma * 30 Angiomatous meningioma 15 Ependymoma 12 Papillary ependymoma 6 Anaplastic ependymoma 2 Cellular ependymoma 1 Hemangioblastoma
Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific
Effective January 1, 2018 codes, behaviors and terms are site specific /N 8551/3 Acinar adenocarcinoma (C34. _) Lung primaries diagnosed prior to 1/1/2018 use code 8550/3 For prostate (all years) see 8140/3
Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific
Effective January 1, 2018 codes, behaviors and terms are site specific Status /N 8010/3 Urachal carcinoma (C65.9, C66.9, C67. _, C68._) 8013/3 Combined large cell neuroendocrine carcinoma (C34. _, C37.9)
2018 ICD-O-3 Updates in Table Format with Annotation for Reference
Status Histology Description (this may be preferred term or a synonym) Report Comments New term 8010 3 Urachal carcinoma (C65.9, C66.9, C67._, C68._) New term 8013 3 Combined large cell neuroendocrine
2 Berkeley Street, Suite 403, Toronto, Ontario M5A 2W3 Visit us at: Tel: Fax:
E-Path A.I. Engine Knowledge Base Enhancements Version 1.0.0.29 April 1, 2018 The major enhancements in the E-Path Knowledge Base from versions 1.0.0.28 through 1.0.0.29 are as follows: 1. Addition/modification
Appendix 4: WHO Classification of Tumours of the pancreas 17
S3.01 The WHO histological tumour type must be recorded. CS3.01a The histological type of the tumour should be recorded based on the current WHO classification 17 (refer to Appendices 4-7). Appendix 4:
Contents Part I Introduction 1 General Description 2 Natural History: Importance of Size, Site, Histopathology
Contents Part I Introduction 1 General Description... 3 1.1 Introduction... 3 1.2 Incidence and Prevalence... 5 1.3 Predisposing and Genetic Factors... 8 References... 16 2 Natural History: Importance
ICD-O Morphology code. R=Rare Tier Tumour ICD-O Topography code C30.0, C31
R=Rare Tier Tumour ICD-O Topography code ICD-O Morphology code EPITHELIAL TUMOURS OF NASAL CAVITY AND SINUSES R 2 Squamous cell carcinoma with variants of nasal cavity and sinuses C30.0, C3 C30.0, C3 8000,
Index. J Juvenile hyaline fibromatosis, 27 Juvenile xanthogranuloma, 57 Juxta-articular myxoma, 152
A Adenomatoid tumor, 76, 77 Adipose tissue tumors benign tumors angiolipoma, 6 chondroid lipoma, 9 fibrolipoma, 5 hibernoma, 8 lipoblastoma, 9 lipoma (see Lipoma) myelolipoma, 6 pleomorphic lipoma, 8 spindle
* Speaker's diagnosis
* Speaker's diagnosis Creutzfeldt-Jacob disease(cjd) 5 Prion disease( Creutzfeldt-Jakob disease ) 3 Extrapontine myelinolytis 5 Subacute sclerosing panencephalitis (SSPE) 5 Central pontine myelinolysis
Gross appearance of peritoneal cysts. They have a thin, translucent wall and contain a clear fluid.
Gross appearance of peritoneal cysts. They have a thin, translucent wall and contain a clear fluid. So-called multicystic benign mesothelioma. A, Gross appearance. So-called multicystic benign mesothelioma.
Differential Diagnosis of Oral Masses. Palatal Lesions
Differential Diagnosis of Oral Masses Palatal Lesions Palatal Masses Periapical Abscess Torus Palatinus Mucocele Lymphoid Hyperplasia Adenomatous Hyperplasia Benign Salivary Neoplasms Malignant Salivary
INDEX. in this web service Cambridge University Press
abscess. See also subareolar abscess acute mastitis, 44 lactational/puerperal mastitis, 55 mammary tuberculosis, 42 tuberculous, 43 adeno gastric, 198, 200 invasive, 157 lung, 197, 200 prostatic, 199 200
Surveys and Anatomic Pathology Education Programs
Surveys and Anatomic Pathology Education Programs Performance Improvement Program in Surgical Pathology PIP/PIPW-B 2018 Participant Summary 2018 College of American Pathologists. The College does not permit
CURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY
CURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY JULY, 2003 The following is a conceptual curriculum and set of guidelines for Pathology Residents on the Breast
S Y M P O S I U M P R O G R A M
Dear colleagues, dear friends We would like to cordially welcome you to the 10 th International Arkadi M. Rywlin International Pathology Slide Seminar in Anatomic Pathology to be held in Split, Croatia.
Educational Cases EQA November T.J. Palmer Raigmore Hospital Inverness
Educational Cases EQA November 2013 T.J. Palmer Raigmore Hospital Inverness Case 2 Clinical Details Dob 11 February 1951 PMH: 1964 Extraction of 45 aet 13 yr 1966 Cyst between 44 and 46 enucleated 1973
TOTALS 30. Preliminary analysis of NNDEQA 004 (May 2013 TSL workshops) 1) 70 year old female with focal irregularity in the right breast.
-- Preliminary analysis of NNDEQA 00 (May 0 TSL workshops) ) 70 year old female with focal irregularity in the right breast. Fat necrosis (with organising thrombus/foreign body granuloma/surgical site
BSG/TSL GI workshops EQA011 preliminary response analysis
BSG/TSL GI workshops 06 EQA0 preliminary response analysis GI Neoplasia case Female 68 years Oesophagus Tumour TN0 pre-op staging : No chemotherapy Adenoid cystic carcinoma (pt) Adenocarcinoma (ptb, ptbn)
Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node
Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node Oil Cyst Mass, Intermediate Concern Microlobulated Margins Obscured Margins Mass, Favoring Malignant Indistinct
incidence rate x 100,000/year
Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European
Case year female. Routine Pap smear
Case 1 57 year female Routine Pap smear Diagnosis? 1. Atypical glandular cells of unknown significance (AGUS) 2. Endocervical AIS 3. Endocervical adenocarcinoma 4. Endometrial adenocarcinoma 5. Adenocarcinoma
Anatomic Pathology Study Sets Glass Slides
Anatomic Pathology Study Sets Glass Slides Effective July 19, 2018 California Tumor Tissue Registry 11021 Campus Street, AH335, Loma Linda, Ca 92350 (909) 558-4788; Fax (909) 558-0188 E-Mail: cttr@llu.edu
Contents. Basic Ultrasound Principles and Terminology. Ultrasound Nodule Characteristics
Contents Basic Ultrasound Principles and Terminology Basic Ultrasound Principles... 1 Ultrasound System... 2 Linear Transducer for Superficial Images and Ultrasound-Guided FNA... 3 Scanning Planes... 4
Final analysis of NNDEQA 004 (May 2013 TSL workshops) 1) 70 year old female with focal irregularity in the right breast.
Final analysis of NNDEQA 00 (May 0 TSL workshops) ) 70 year old female with focal irregularity in the right breast. CONSUL TANTS Fat necrosis (with organising thrombus/foreign body granuloma/surgical site
Pathology of Mediastinal Tumors
SAMO Meeting Lucerne 2009 Pathology of Mediastinal Tumors Alex Soltermann Most common lesions (adults) Clinical presentation 50% of the patients are asymptomatic, lesion discovered incidentally Symptoms
BSG/TSL GI workshops EQA011 final response analysis with diagnoses
BSG/TSL GI workshops 2016 EQA011 final response analysis with diagnoses GI Neoplasia case 1 Female 68 years Oesophagus Tumour T2N0 pre-op staging : No chemotherapy Adenoid cystic carcinoma (pt1) 4 Adenocarcinoma
2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING
2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING Eight Groups are Revised for 2018 Head & Neck Colon (includes rectosigmoid and rectum for cases diagnosed 1/1/2018 forward) Lung (2018 Draft not yet
ARIZONA SOCIETY OF PATHOLOGISTS 13 TH APRIL 2013 HEAD AND NECK CYTOPATHOLOGY. F ZAHRA ALY, MD, PhD
ARIZONA SOCIETY OF PATHOLOGISTS 13 TH APRIL 2013 HEAD AND NECK CYTOPATHOLOGY F ZAHRA ALY, MD, PhD The main areas sites amenable for cytopathology include lymph nodes, thyroid, major salivary glands especially
Spindle Cell Lesions Of The Breast. Emad Rakha Professor of Breast Pathology and Consultant Pathologist
Spindle Cell Lesions Of The Breast Emad Rakha Professor of Breast Pathology and Consultant Pathologist * SCLs comprise a wide spectrum of diseases, ranging from reactive processes to aggressive malignant
INDEX. in this web service Cambridge University Press
actin 14 adamantinoma 202, 290 292, 297 adenocarcinoma 136 adipocytes in hibernoma 149, 150 in lipoblastoma 148 in lipoma 141, 142, 145 in liposarcoma 152 in myelolipoma 151 adrenal gland tumors see myelolipoma
Anatomic Pathology Study Sets Glass Slides
Anatomic Pathology Study Sets Glass Slides Effective January 1, 2015 California Tumor Tissue Registry 11021 Campus Street, Ah335, Loma Linda, Ca 92350 (909) 558-4788; Fax (909) 558-0188 E-Mail: cttr@llu.edu
Breast - ductal carcinoma CK7 ER PR GATA3 Mammaglobin (50-70%) GCDFP-15 (50-70%) E-cadherin HMWCK CK20 PAX2 ER/PR/HER2 on all newly diagnosed cases
Adrenal cortical carcinoma Inhibin Synap Melan-A Calretinin Vimentin Chromogr CK7 CK20 Breast - ductal carcinoma CK7 ER PR GATA3 Mammaglobin (50-70%) GCDFP-15 (50-70%) E-cadherin HMWCK CK20 PAX2 ER/PR/HER2
Salivary Gland Cytology
Salivary Gland Cytology Diagnostic challenges and potential pitfalls Tarik M. Elsheikh, MD Professor and Medical Director Anatomic Pathology Cleveland Clinic FNA Salivary Gland Lesions Indications Distinguish
Anatomic Pathology Study Sets Glass Slides
Anatomic Pathology Study Sets Glass Slides California Tumor Tissue Registry 11021 Campus Street, AH335, Loma Linda, Ca 92350 (909) 558-4788; Fax (909) 558-0188 E-Mail: cttr@llu.edu Web Site: www.cttr.org
Other Sites. Table 2 Continued. MPH Rules 11/8/07. NAACCR Webinar Series 1
MPH s 11/8/07 Other s 1 Table 2 Continued Use this two-page table to select combination histology codes. Compare the terms in the diagnosis to the terms in Columns 1 and 2. If the terms match, code the
CODING TUMOUR MORPHOLOGY. Otto Visser
CODING TUMOUR MORPHOLOGY Otto Visser INTRODUCTION The morphology describes the tissue of the tumour closest to normal tissue Well differentiated tumours are closest to normal Undifferentiated tumours show
Review of the AP Part II Practical Examination. Dr David Clift Co Chief Examiner
Review of the AP Part II Practical Examination Dr David Clift Co Chief Examiner General Remarks The part II practical examination involved 15 cases which were presented with sufficient clinical data to
Diagnostic Approach to Soft Tissue Tumors
SECTION 2 Diagnostic Approach to Soft Tissue Tumors Overview Biopsy and Resection of Soft Tissue Tumors 20 Clinical Approach Age- and Location-Based Approach to Diagnosis 24 Histologic Approach Pattern-Based
Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction
Disclosures An update on ancillary techniques in the diagnosis of soft tissue tumors. I have nothing to disclose. Andrew Horvai, MD, PhD Clinical Professor, Pathology Introduction Ancillary techniques
Salivary Glands 3/7/2017
Salivary Glands 3/7/2017 Goals and objectives Focus on the entities unique to H&N Common board type facts Information for your future practice Salivary Glands Salivary Glands Major gland. Paratid. Submandibular.
List of Available TMAs in the PRN
TMA RPCI_BrainCa01 RPCI_BrCa03 RPCI_BrCa04 RPCI_BrCa05 RPCI_BrCa0 RPCI_BrCa07 RPCI_BrCa08 RPCI_BrCa15 RPCI_BrCa1 RPCI_BrCa17 RPCI_BrCa18 RPCI_BrCa19 RPCI_BrCa20 RPCI_BrCa21 RPCI_BrCa24 RPCI_BrCa25 RPCI_BrCa2
Case E1. Female aged 63 years Right Nephrectomy Two separate tumours Section of each tumour
Case E1 Female aged 63 years Right Nephrectomy Two separate tumours Section of each tumour Tumour 1 Upper pole tumour 28mm macro diameter Circumscribed Friable cut surface Tumour 2 Middle pole Part solid
4/17/2015. Case 1. A 37 year old man with a 2.2 cm solitary left thyroid mass.
Case 1 A 37 year old man with a 2.2 cm solitary left thyroid mass. Case 1 Case 1 1 Case 1: Diagnosis? A. Benign B. Atypia of undetermined significance/follicular lesion of undetermined significance C.
Breast pathology. 2nd Department of Pathology Semmelweis University
Breast pathology 2nd Department of Pathology Semmelweis University Breast pathology - Summary - Benign lesions - Acute mastitis - Plasma cell mastitis / duct ectasia - Fat necrosis - Fibrocystic change/
Dr Sanjiv Manek Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust
Dr Sanjiv Manek Oxford Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust Ovarian Endometrial Vulvo-vaginal Cervical Illustration-Cellular Pathology. Oxford
Index* Biphasic carcinoma, 267 Black thyroid, 104 BRAF genes, 37 BRAF mutations, in papillary carcinoma, 371
Index* A ADASP (Association of Directors of Anatomic and Surgical Pathology) reporting protocol, 468 Adenochondroma, 78 Adenoid cystic carcinoma, 320 Adenoid cystic variant of papillary carcinoma, 431
Objectives. Salivary Gland FNA: The Milan System. Role of Salivary Gland FNA 04/26/2018
Salivary Gland FNA: The Milan System Dr. Jennifer Brainard Section Head Cytopathology Cleveland Clinic Objectives Introduce the Milan System for reporting salivary gland cytopathology Define cytologic
Slide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana
Slide seminar Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana Case 5 A 57-year-old man with a dermal/subcutaneous lesion on the scalp, which was interpreted
Normal endometrium: A, proliferative. B, secretory.
Normal endometrium: A, proliferative. B, secretory. Nội mạc tử cung Nội mạc tử cung Cyclic changes in endometrium.. Approximate relationship of useful microscopic changes. Arias-Stella reaction in endometrial
Vulva Inflammatory Disorders Lichen Planus Fixed Drug Eruption Erythema Multiforme Plasmacytosis Mucosae (Zoon) Lichen Sclerosus Allergic Contact
Vulva Inflammatory Disorders Lichen Planus Fixed Drug Eruption Erythema Multiforme Plasmacytosis Mucosae (Zoon) Lichen Sclerosus Allergic Contact Dermatitis Psoriasis Lichen Simplex Chronicus Foreign Body
Performance Improvement Program in Surgical Pathology
PIP-A Performance Improvement Program in Surgical Pathology PARTICIPANT SUMMARY 2009 College of American Pathologists. The College does not permit reproduction of any substantial portion of the material
Oncocytic-Appearing Salivary Gland Tumors. Oncocytic, Cystic, Mucinous, and High Grade Salivary Gland Tumors SALIVARY GLAND FNA: PART II
William C. Faquin, MD, PhD Professor of Pathology Harvard Medical School Director of Head and Neck Pathology Massachusetts Eye and Ear Massachusetts General Hospital SALIVARY GLAND FNA: PART II Oncocytic,
Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction
Disclosures An update on ancillary techniques in the diagnosis of soft tissue tumors. I have nothing to disclose. Andrew Horvai, MD, PhD Clinical Professor, Pathology Introduction Ancillary techniques
2010 Update. NAACCR Webinar Series 1 4/1/2010. Agenda. Access to 2010 Information. CSv2. Collecting Cancer Data: Soft Tissue Sarcoma
NAACCR 2009 2010 Webinar Series Collecting Cancer Data: Soft Tissue Sarcoma, Neuroendocrine Tumors (NET) and Gastrointestinal Stromal Tumors (GIST) Agenda Updates Soft Tissue Sarcoma Overview CSv2 MP/H
5/10. Pathology Soft tissue tumors. Farah Bhani. Mohammed Alorjani
5/10 Pathology Soft tissue tumors Mohammed Alorjani Farah Bhani Slides are included in this sheet. Objectives: Soft tissue tumors 1. Describe soft tissue tumors. 2. Understand the classification of soft
Surveys and Anatomic Pathology Education Programs
Surveys and Anatomic Pathology Education Programs Performance Improvement Program in Surgical Pathology PIP/PIPW-C 2018 Participant Summary 2018 College of American Pathologists. The College does not permit
SURVEYS 2013 INDEX CASE SUMMARY REPORT. Performance Improvement Program in Surgical Pathology AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS
INDEX Performance Improvement Program in Surgical Pathology SURVEYS 2013 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS 1989-2013 CASE SUMMARY REPORT 2013 College of American Pathologists. The College does
16 Nuchal Fibroma and Gardner
C O N T E N T S Dedication v Preface vii Acknowledgments ix SECTION 1 Fibrohistiocytic Tumors 1 1 Classification of Fibrohistiocytic Tumors 3 2 Dermatofibroma 5 3 Juvenile Xanthogranuloma 33 4 5 6 Solitary
EQA Circulation 43 Educational Cases
EQA Circulation 43 Educational Cases E1-E2 Monica Agarwal Monklands Hospital E1 38 yrs male Submandibular gland tumour E1 Formal excision following diagnosis of poorly differentiated carcinoma on core
FNA OF SALIVARY GLANDS: A PRACTICAL APPROACH
FNA OF SALIVARY GLANDS: A PRACTICAL APPROACH FNA of Salivary Glands: Challenges Wide range of neoplastic and non-neoplastic lesions Cytological overlap between the different benign and malignant tumors
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat version (downloaded 3/23/2017)
APPENDIX I. SEER Search criteria and exclusion criteria. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat version 8.3.4 (downloaded 3/23/2017) SEER*Stat Database:
LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR
BREAST LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR HISTOLOGY LOBE: (10 in whole breast) LOBULE: (many per lobe) ACINUS/I, aka ALVEOLUS/I: (many per lobule) DUCT(S): INTRA- or
Benign Mimics of Malignancy in Breast Pathology
Arthur Purdy Stout Society of Surgical Pathologists Companion Meeting Benign Mimics of Malignancy in Breast Pathology Stuart J. Schnitt, M.D. Beth Israel Deaconess Medical Center and Harvard Medical School,
FINALIZED SEER SINQ QUESTIONS
0076 Source 1: WHO Class CNS Tumors pgs: 33 MP/H Rules/Histology--Brain and CNS: What is the histology code for a tumor originating in the cerebellum and extending into the fourth ventricle described as
Table of Contents. Preface xi. Acknowledgments xiii. Part I Overview of the Diagnostic Process 1. 1 Overview of Grading and Staging 3
Table of Contents Preface xi Acknowledgments xiii Part I Overview of the Diagnostic Process 1 1 Overview of Grading and Staging 3 Identification of the process 3 Identification of tumor types 5 Grading
Salivary gland Workshop Trondheim 31th may 2012
Salivary gland Workshop Trondheim 31th may 2012 Peter Jebsen cytopathologist Oslo University Hospital Rikshospitalet Anna Bofin ass. Professor St. Olavs Hospital, Trondheim Drying artifacts Lymfocytes
2007 Multiple Primary and
2007 Multiple Primary and Histology Coding Rules Beyond the Basics Florida Cancer Data System Annual Conference Tampa, FL July 26,2007 Steven Peace, CTR Westat Carol Johnson, CTR NCI SEER Peggy Adamo,
Lesions Mimicking Adenoid Cystic Carcinoma. Diagnostic Problems in Salivary Gland Pathology An Update 5/29/2009
Diagnostic Problems in Salivary Gland Pathology An Update Lesions Mimicking Adenoid Cystic Carcinoma Stacey E. Mills, M.D. W.S. Royster Professor of Pathology Director of Surgical and Cytopathology University
Recent advances in breast cancers
Recent advances in breast cancers Breast cancer is a hetrogenous disease due to distinct genetic alterations. Similar morphological subtypes show variation in clinical behaviour especially in response
SURVEYS 2016 INDEX. Performance Improvement Program in Surgical Pathology CASE SUMMARY REPORT AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS
INDEX Performance Improvement Program in Surgical Pathology SURVEYS 2016 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS 1989-2016 CASE SUMMARY REPORT 2016 College of American Pathologists. The College does
04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA
Intraductal Papillary Neoplasms Of Breast Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head The University of Texas MD Anderson Cancer Center 25 th Annual Seminar in Pathology Pittsburgh,
Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of
Tiền liệt tuyến Tiền liệt tuyến Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of solid and microcystic areas.
Appendix E SEER Program Coding and Staging Manual DRAFT Reportable Examples
Appendix E1 2018 SEER Program Coding and Staging Manual DRAFT Reportable Examples Malignant # Diagnosis/Condition Notes 1 Atypical fibroxanthoma (superficial malignant fibrous histiocytoma) 2 Positive
Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON
Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON Presentation outline Background and epidemiology of sarcomas Sarcoma classification Sarcoma
Lung Tumor Cases: Common Problems and Helpful Hints
Lung Tumor Cases: Common Problems and Helpful Hints Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona Society of Pathologists
Contents. vii. Preface... Acknowledgments... v xiii
Contents Preface... Acknowledgments... v xiii SECTION I 1. Introduction... 3 Knowledge-Based Diagnosis... 4 Systematic Examination of the Lymph Node... 7 Cell Type Identification... 9 Cell Size and Cellularity...
SHN-1 Human Digestive Panel Test results
SHN-1 Human Digestive Panel Test results HN-30 tongue HN-24 salivary gland HN-12 larynx HN-28 esophagus HN-29 stomach HN-20 pancreas HN-13 liver HN-14 gall bladder HN-27-1 duodenum HN-27-2 ileum HN-27-3
Enterprise Interest None
Enterprise Interest None What are triple negative breast cancers? A synopsis of their histological patterns Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology,
Performance Improvement Program in Surgical Pathology
PIP-D Performance Improvement Program in Surgical Pathology PARTICIPANT SUMMARY 2008 College of American Pathologists. The College does not permit reproduction of any substantial portion of the material
ANNUAL CANCER REGISTRY REPORT-2015
CANCER STATISTICS Distribution of neoplasms ANNUAL CANCER REGISTRY REPORT-2015 Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Hina Asif, Adna Atif, Farhana Badar Of a total of 5,924 new neoplasms diagnosed
Los Angeles Society Of Pathologists Dr. Shobha Castelino Prabhu
Los Angeles Society Of Pathologists Dr. Shobha Castelino Prabhu Loma Linda University Medical Center June 12, 2007 CASE 1 76 year-old gentleman Status post right parotidectomy 1 year ago for a rare tumor
Diseases of the breast (1 of 2)
Diseases of the breast (1 of 2) Introduction A histology introduction Normal ducts and lobules of the breast are lined by two layers of cells a layer of luminal cells overlying a second layer of myoepithelial
Vascular. Extravasated blood. Melanocytic. Tattoo. Epidermolysis bullosa. Lichen planus. Pemphigoid Pemphigus Lupus. Candidosis. Surface Epithelial
Oral Soft Tissue Pathology Epithelial Thickening (white) Combination Erythema migrans Epithelial atrophy (red) Surface Lesions Clinical Impression Enlargements Surface Debris Pigmented Vesicular Ulcerated
Rare cancers are those with an incidence rate 6/100,000
Rare cancers are those with an incidence rate 6/100,000 Layer Tumour Rate x 100,000 Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES 0.44 3,594 2 Squamous cell carcinoma and variants of the
Mody. AIS vs. Invasive Adenocarcinoma of the Cervix
Common Problems in Gynecologic Pathology Michael T. Deavers, M.D. Houston Methodist Hospital, Houston, Texas Common Problems in Gynecologic Pathology Adenocarcinoma in-situ (AIS) of the Cervix vs. Invasive
FNA Biopsy of Salivary Gland
FNA Biopsy of Salivary Gland Richard M. DeMay, MD Professor of Pathology Director of Cytopathology The University of Chicago Objective: To describe the use of FNA Bx to diagnose salivary gland lesions
PIP-D SURVEYS Performance Improvement Program in Surgical Pathology AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS
PIP-D Performance Improvement Program in Surgical Pathology SURVEYS 2012 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS 2012 PIP/PIPW-D PARTICIPANT SUMMARY Program Update This report summarizes the diagnostic
第 121 回中国四国スライドカンファレンス投票結果
第 121 回中国四国スライドカンファレンス投票結果 S2633 肝腫瘤 Angiosarcoma 4 Hemangioendothelioma 9 Epithelioid 7 Atypical 1 Sclerosed hemangioma 11 Ancient hemangioma 1 Angiomyxoma 7 Aggressive angiomyxoma 4 Embryonal sarcoma
Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES Squamous cell carcinoma and variants of the Nasal Cavity
Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES 0.471 3060 2 Squamous cell carcinoma and variants of the Nasal Cavity and Sinuses 0.37 2615 3 Squamous carcinoma 0.24 1708
Methoden / Methods inc. ICCC-3 105
Methoden / Methods inc. ICCC-3 105 Internationale Klassifikation der Krebserkrankungen bei Kindern (ICCC-3) Zuordnung von ICD-O-3-Codes für Morphologie und Topographie zu diagnostischen Kategorien International
Diagnostic Cytology of Cancer Cases
Diagnostic Cytology of Cancer Cases Somporn Techangamsuwan Companion Animal Cancer Research Unit (CAC-RU) Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University 1 Tumor or Non-tumor
Tumour Structure and Nomenclature. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge
Tumour Structure and Nomenclature Paul Edwards Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge Malignant Metastasis Core idea of cancer Normal Cell Slightly
Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC
R/O BCC Sabine Kohler, M.D. Professor of Pathology and Dermatology Dermatopathology Service Stanford University School of Medicine Clinical Information 74 y.o. man with lesion on left side of neck r/o
Spontaneous Neoplastic Lesions in the Crl:CD-1 (ICR)BR Mouse. March, 2000
Spontaneous Neoplastic Lesions in the Crl:CD-1 (ICR)BR Mouse March, 2000 Information Prepared by Mary L. A. Giknis, Ph.D. Charles B. Clifford, D.V.M., Ph.D. CHARLES RIVER LABORATORIES TABLE OF CONTENTS
Atlas of Eyelid and Conjunctival Tumors
Atlas of Eyelid and Conjunctival Tumors Jerry A. Shields, M.D. Director, Ocular Oncology Service Wills Eye Hospital Professor of Ophthalmology Thomas Jefferson University Philadelphia, Pennsylvania Carol
Notice of Faculty Disclosure
Mesenchymal Tumors of the Vulva: Old, New, Something(s) Different Napa Valley Conference Pathology Education Partners Inc May 15, 2018 Teri A. Longacre, M.D. longacre@stanford.edu Stanford University,
ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN
ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Ain ul Quader, Hina Asif, Adna Atif, Lubna Nadeem,
Grading of Bone Tumors
Grading of Bone Tumors Joon Hyuk Choi, M.D. Department of Pathology College of Medicine, Yeungnam University Introduction to grading system of bone tumor used at Mayo Clinic WHO Histologic Classification
Index. C Calcifications fat necrosis 1, 61 fat necrosis 4, 69 nipple/peri-areolar involvement 1, 165
A ADH. See Atypical ductal hyperplasia (ADH) American College of Radiology (ACR), BI-RADS background parenchymal enhancement, 8, 9, 81, 82 fibroglandular tissue guidelines, 6 American Joint Committee on